secwatch.observer — SEC 8-K summary
======================================

Issuer:     Surgery Partners, Inc. (SGRY)
CIK:        0001638833
Form:       8-K
Filed at:   2022-08-02T23:59:59+00:00
Accession:  0001638833-22-000120
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Surgery Partners Q2 revenue up 13.3% to $615.4M; Adj EBITDA up 13.4% to $86.1M
------------------------------------------------------------------------------

- Revenue $615.4M vs $543.3M; net loss $18.4M vs $26.9M in prior year quarter.
- Days adjusted same-facility revenues up 6.9%; cases +1.9%, revenue per case +4.9%.
- Adj EBITDA ex-CARES grants up 17.8% to $86.0M; margin 14.0%.
- 2022 guidance reaffirmed: revenue $2.5-2.6B, Adj EBITDA $375-385M.
- Deployed ~$90M in six acquisitions at ~7x average multiple; liquidity $227.4M cash plus $203M revolver.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638833/000163883322000120/0001638833-22-000120-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638833/000163883322000120/sgry-20220802.htm
  HTML page:      https://secwatch.observer/filing/0001638833-22-000120

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer